OraSure Technologies Set to Share Q3 2025 Financial Insights
BETHLEHEM, Pa. — OraSure Technologies, Inc. (NASDAQ: OSUR) is excited to announce its upcoming earnings conference call, which will take place at 5 p.m. ET on November 5, 2025. This session will cover key financial results for the third quarter of 2025, as well as significant developments within the company.
How to Access the Earnings Call
Investors and interested parties can join the call via a webcast that will be hosted on the investor relations section of OraSure’s official website. To ensure a smooth experience, it’s recommended that participants click on the webcast link and follow the registration prompts at least 10 minutes before the call begins.
About OraSure Technologies
OraSure Technologies, Inc. is a pioneering force in health solutions, focusing on actionable insights that democratize access to healthcare. The company has made it its mission to enhance the accessibility, quality, and value of healthcare through innovative diagnostic tools and easy-to-use testing solutions. With strategic subsidiaries, including DNA Genotek Inc. and Sherlock Biosciences, Inc., OraSure is recognized as a leader in rapid diagnostic tests and sample collection devices.
A Commitment to Improving Healthcare
At the core of OraSure’s mission is a commitment to transforming health. By decentralizing diagnostics, the company connects people with vital healthcare services no matter where they are. The array of products offered by OraSure aims to identify critical medical conditions effectively and promptly, catering to various sectors. Their portfolio is sold globally, reaching clinical laboratories, hospitals, physician's offices, and public health organizations, ensuring that essential healthcare tools are within reach.
Innovative Solutions for Diverse Needs
OraSure continues to lead the way in developing state-of-the-art testing solutions that facilitate healthcare providers in offering timely diagnoses. Their innovations not only streamline sample collection and stabilization but also enhance the patient experience, making it easier for individuals to access necessary testing.
Comprehensive Support for Stakeholders
For those looking to connect with OraSure for further inquiries, the company provides dedicated support through its investor and media contacts. Jason Plagman serves as the Vice President of Investor Relations, while Amy Koch holds the title of Director of Corporate Communications. Interested parties can reach out via email for inquiries or further information regarding financial matters and media relations.
Investor Relations
For investment-related questions, Jason Plagman can be reached at investorinfo@orasure.com. His team is ready to provide information about the company’s financial performance and upcoming initiatives that showcase OraSure’s leadership in healthcare innovation.
Media Relations
Amy Koch is the point of contact for media inquiries. Journalists and media professionals seeking insights about OraSure’s products, corporate developments, or other news can email her at media@orasure.com for assistance.
Frequently Asked Questions
What is OraSure Technologies, Inc.?
OraSure Technologies, Inc. specializes in health diagnostics and solutions that improve access to healthcare through innovative testing technologies.
When is the earnings call scheduled?
The earnings call is scheduled for 5 p.m. ET on November 5, 2025, covering Q3 financial results.
How can I access the earnings call?
The earnings call can be accessed via a webcast on OraSure’s investor relations webpage, with recommendations to register 10 minutes prior to the start.
Who can I contact for investor inquiries?
For investor inquiries, Jason Plagman, VP of Investor Relations, is available through the email investorinfo@orasure.com.
What innovations does OraSure bring to healthcare?
OraSure develops rapid diagnostic tests and sample management solutions that enhance healthcare accessibility and efficiency, making diagnostics more effective for a range of medical conditions.
